Inhaltsverzeichnis
The need for reviews and comprehensive field guides is urgent due to the recent surge of research into psychedelic mushrooms along with public interest. Psilocybin and psilocin are recorded in mushroom species of Psilocybe, Panaeolus, Pluteus, and Gymnopilus. This review discusses species identification, taxonomy and classification, available DNA sequence data and psychedelic species in Psilocybe, Panaeolus, Pluteus, and Gymnopilus, as well as similar looking genera that could be harmful. The efficacy of microdosing to enhance mood, creativity and cognition and to reduce anxiety and depression is supported by anecdotal accounts [17] and, more recently, by online surveys, observational, and open-label studies [7,8,9, 18,19,20, 27,28,29].
- Now, in a follow-up study of those participants, the researchers report that the substantial antidepressant effects of psilocybin-assisted therapy, given with supportive psychotherapy, may last at least a year for some patients.
- Psilocybin mushrooms are illegal in the United States because they contain the Schedule I drugs psilocybin and psilocin.
- CBT focuses on helping people change thought and behavior patterns that contribute to substance use, while MET works to improve people's motivation to change.
- In 2022, the Connecticut legislature started the process of legalizing centers in which veterans and first responders could take psilocybin.
- A growing body of research suggests that, when administered in controlled conditions with supportive therapy, the compound may be useful for treating various psychiatric disorders, like depression.
- With the foundation already laid, future research on these increasingly important fungi should be easily accomplished.
In 2022, the Connecticut legislature started the process of legalizing centers in which veterans and first responders could take psilocybin. Magic mushrooms are undergoing a transformation from illicit recreational drug to promising mental health treatment. Numerous studies have reported positive findings using psilocybin—the mushrooms' main psychoactive compound—for treating depression as well as smoking and alcohol addiction, and for reducing anxiety in the terminally ill.
Magic Mushroom Tolerance, Dependence, and Withdrawal
Axfordii is the most recent novel species that has also been reported to have psychedelic properties (Figure 1E; Hu et al., 2020). Morphological characteristics of Psilocybe species often include bluing, indicative of the presence of psilocybin, for example, recently described in Psilocybe chuxiongensis, Psi. Thaizapoteca (Guzmán et al., 2012; Li et al., 2014; Ma et al., 2014). Psilocybin can be accurately measured in bluing species using physico-chemical methods (Passie et al., 2002). Thirty-three and 55 species of Psilocybe have been shown to be positive for psilocybin using physico-chemical methods (Wurst et al., 2002; Andersson et al., 2009).
Psychedelics Research and Psilocybin Therapy
It also reduced anxiety and increased energy and friendliness. Several types of poisonous mushrooms closely resemble psilocybin mushrooms. It can be very dangerous to attempt to identify psilocybin mushrooms on your own.
https://acsauhaya.org/team/ >What to Know About Shrooms
Psilocybin and psilocin are commonly found in Gymnopilus species (Andersson et al., 2009). At least 16 species of Gymnopilus are considered psychedelic, including G. Viridans (Hatfield and Valdes, 1978; Guzmán et al., 1998; Holec et al., 2003; Guzmán-Dávalos and Herrera, 2006).